Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021
Zymergen Inc. (Nasdaq: ZY) will announce its third-quarter 2021 financial results on November 3, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Zymergen Inc. (Nasdaq: ZY) will announce its third-quarter 2021 financial results on November 3, 2021, after market close. A conference call hosted by management will take place at 1:30 p.m. PT (4:30 p.m. ET) to discuss results, business developments, and future outlook. Investors can access a webcast of the call on Zymergen's investor relations website. Zymergen specializes in biofacturing, using a blend of biology, chemistry, software, and automation to create innovative bio-based products.
Positive
- Company will share 3Q 2021 financial results, providing insights into its financial health.
- Management conference call scheduled for November 3, allows investor engagement.
- Zymergen's focus on biofacturing suggests potential for growth in diverse industries.
Negative
- None.
Details
News Market Reaction – ZY
The recorded move for ZY in the trading session of this news was +2.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (Nasdaq: ZY) today announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
A webcast of the conference call can be accessed at https://investors.zymergen.com/.
About Zymergen
Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Investor Contact
Carrie Mendivil/Mary Kate McDonough
investors@zymergen.com
Media Contact
Mike Dulin
mdulin@zymergen.com
502-777-2029
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.